Dr. Timmerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8525Fax+1 214-645-9233
Education & Training
- Johns Hopkins UniversityResidency, Radiation Oncology, 1991 - 1994
- University of South DakotaInternship, Transitional Year, 1990 - 1991
- University of South Dakota, Sanford School of MedicineClass of 1990
- University of Tennessee SystemMS, Reactor Physics, 1986
- Iowa State UniversityBS, Nuclear Engineering, 1983
Certifications & Licensure
- TX State Medical License 2004 - 2026
- IN State Medical License 1994 - 2017
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Staff Appreciation Award Department of Radiation Oncology, UTSW, 2014
- George Edelstyn Lecture Award Royal College of Radiologists, 2014
- Join now to see all
Clinical Trials
- Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer Start of enrollment: 2004 May 01
- Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2007 Jun 25
- Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2006 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 110 citationsStereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.Raquibul Hannan, Vasu Tumati, Xian Jin Xie, L. Chinsoo Cho, Brian D. Kavanagh
European Journal of Cancer. 2016-05-01 - 12 citationsPreliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa.Howard E Morgan, Kai Wang, Yulong Yan, Neil Desai, Raquibul Hannan
Practical Radiation Oncology. 2022-12-10 - 733 citationsRadiation dose-volume effects in the lung.Lawrence B. Marks, Søren M. Bentzen, Joseph O. Deasy, Feng-Ming Spring Kong, Jeffrey D. Bradley
International Journal of Radiation Oncology, Biology, Physics. 2010-03-01
Journal Articles
- Neutrophil-lymphocyte and Platelet-lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-stage Non-small-cell Lung CancerCannon NA, Meyer J, Iyengar P, et al., J Thorac Oncol., 1/1/2015
- A Retrospective Analysis of Tumor Volumetric Responses to Five-fraction Stereotactic Radiotherapy for Paragangliomas of the Head and Neck (Glomus Tumors)Chun SG, Nedzi LA, Choe KS, et al., Stereotact Funct Neurosurg., 1/1/2014
- Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation StudyKim DW, Straka C, Cho LC, Timmerman RD., Frontiers in Oncology., 1/1/2014
- Join now to see all
Books/Book Chapters
Lectures
- Stereotactic Body Radiation Therapy: Toward the Proper Implementation of Technical and Biological InnovationBethesda, MD - 1/1/2006
- Evolution of Stereotactic Radiation DeliveryIndiana University Medical Center, Indianapolis, IN - 1/1/2004
- Dose-Volume Statistics: Applications in Stereotactic RadiosurgeryIndiana University Medical Center, Indianapolis, IN - 1/3./1994
- Join now to see all
Other
- Stereotactic Ablative Radiotherapy Uncertainties: Delineation, Setup and Motion☆Robert Timmerman, MD, ScienceDirect
https://www.doximity.com/articles/0615bcad-47ce-4b58-9925-bd21642a7b2a
UpToDate, Wolters Kluwer Health - 2012-11-12
Authored Content
- Real-Time Whole Brain Radiotherapy: A Single Institution ExperienceDecember 2017
Press Mentions
- Clinical Trial Sets Stage for New Paradigm in Kidney Cancer TreatmentAugust 18th, 2022
- With $71 Million Radiotherapy Expansion, UT Southwestern Spearheads Adaptive TreatmentsAugust 30th, 2021
- PULSAR Radiation Therapy: UT Southwestern Physicians Develop New AI Strategy to Improve Tumor ControlAugust 21st, 2021
- Join now to see all
Grant Support
- Extracranial Stereotactic Radioablation In Lung CancerNational Cancer Institute2003
- Phase 1b/Ii Repetitive Dose Trial Of Gadolinium Texaphyrin InjectionNational Center For Research Resources1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: